![Mohammed Khoso Baluch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 47 014 $ au 31/05/2026
Mohammed Khoso Baluch is currently an Independent Director at Processa Pharmaceuticals, Inc. since 2022 and an Independent Director at Relevant Biosciences, Inc. Former positions include Chief Executive Officer & Director at CorMedix, Inc. from 2020 to 2021, Chairman at Da Volterra SA from 2021 to 2022, Director & Senior VP & President-Europe Region at UCB, Inc. from 2008 to 2016, VP-US Diabetes & Family Health Business Unit at Eli Lilly & Co. from 2002 to 2008, and Senior VP & President-EMEA Region at UCB SA from 2015 to 2016.
Other former roles include Chairman at multiple UCB Pharma entities, Director roles at JDRF International, Juvenile Diabetes Research Foundation of Arizona, Inc., and UCB Pharma Ltd., Manager at UCB Pharma SA and Vedim Pharma SA, and Independent Director at Longeveron, Inc. from 2023 to 2025.
Education includes undergraduate studies at City University London and an MBA from Cranfield School of Management.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LONGEVERON INC. CLASS A 0,17 % | 11/08/2025 | 52 516 ( 0,17 % ) | 40 542 $ | 31/05/2026 |
| 26/06/2026 | 2 528 ( 0,09 % ) | 6 472 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 11/07/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| LONGEVERON INC. | Directeur/Membre du Conseil | 07/11/2025 |
| POXEL | Président | 31/07/2025 |
Da Volterra SA
 Da Volterra SA BiotechnologyHealth Technology Research and develops bio technology products | Président | 01/11/2022 |
| CORMEDIX INC. | Directeur Général | 04/10/2021 |
| UCB | Corporate Officer/Principal | 01/04/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 19 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
CorMedix, Inc.
 CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
Poxel SA
 Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
UCB Pharma SA
 UCB Pharma SA Chemicals: SpecialtyProcess Industries Manufactures pharmaceutical products | Process Industries |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services Performs research & development on diabetes | Commercial Services |
Vedim Pharma SA
 Vedim Pharma SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
UCB Pharma AS | |
City University London
 City University London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Research and develops bio technology products | Health Technology |
Cranfield School of Management
 Cranfield School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juvenile Diabetes Research Foundation of Arizona, Inc. | |
UCB Pharma Ltd.
 UCB Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
UCB Pharma AB | |
UCB Pharma Sp zoo | |
Longeveron, Inc.
 Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
UCB AE |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
